Stephanie Van Dalen

Stephanie obtained her Ph.D. degree at the department of Experimental Rheumatology, part of the Radboud Institute for Molecular Life Sciences of the Radboud university medical center in Nijmegen. She studied the inhibition of synovitis, the driving force of osteoarthritis, either via neutralization of single inflammatory mediators or via application of versatile adipose-derived mesenchymal stem cells (ASCs) which broadly reduce synovial inflammation. She investigated the working mechanism of ASCs in experimental osteoarthritis, and clarified the close interaction of ASCs with neutrophils.

At Citryll, Stephanie focuses on elucidating the mechanism of action and the identification of new therapeutic applications for CIT-013.